Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Personal financial planning is vital for achieving long-term financial goals. Learn why it matters and how to get started effectively.
24,448 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Discover what to expect from Urban One's 2025 earnings. This guide breaks down revenue drivers, margins, and strategi...
The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a 9.5% yield, backed by 188 holdings and modest leverage. ...
Looking for cash back with zero annual fees? These available credit cards offering cash back no fees rank high for si...
Pollo Loco's 2025 earnings picture blends value-driven demand with store growth and efficiency. This article breaks d...
Eight years, 25 properties, 35 units. This is the real-world story behind deal diaries: cameron philgreen, a Texas in...
A Scattered Spider suspect extradited to the US shines a light on how cross-border cybercrime prosecutions unfold. Th...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
Palo Alto Networks is outperforming Palantir this year, driven by AI-native security demand and margin gains, while i...
Compass International Holdings rolls out its AI-powered Home Platform across its company-owned brands, signaling a ma...
A major fund just increased its stake in Molina Healthcare, while the stock trades lower. This guide breaks down what...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...